Computational Biology Market

""Global Computational Biology market is valued at USD 16.44 billion in 2026 and expected to reach USD 50.88 billion by 2032 with the CAGR of 20.72% over the forecast period.""

Increasing research and development activities on healthcare throughout the world is driving the computational biology market.

Scope of Global Computational Biology Market Report

The study of biological, ecological, behavioral and social systems with the development and application of data-analytical & theoretical methods, mathematical modeling and computational simulation techniques is all together called computational biology. It comprises subjects such as foundation in biology, applied mathematics, statistics, biochemistry, biophysics, molecular biology, genetics, genomics, computer science and evolution. It is different from biological computing as the latter is subfield of computer science and computer engineering in which bioengineering and biology is applied to build computers. But computational biology is similar to bioinformatics, which uses computers to store and process biological data.

Global computational biology market report is segmented on the basis of applications, services, end-user and by regional & country level. Based on application, global computational biology market is classified as cellular and biological simulation, drug discovery and disease modelling, preclinical drug development, clinical trials and human body simulation software. Based upon services, the market is classified as in-house and contract. Based upon the end-user, the market is classified as academics, industry and commercial.

The regions covered in the global computational biology market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Computational Biology Companies:

Global computational biology market report covers prominent players such as,

• Chemical Computing Group Inc
• Compugen Ltd.
• Leadscope Inc.
• Genedata AG
• Accelrys
• Certara
• Insilico Biotechnology AG
• Rhenovia Pharma SAS
• Simulation Plus Inc.
• Entelos
• Nimbus Discovery LLC
• Dassault Systèmes
• Others

Global Computational Biology Market Dynamics–

Technological development in big data application, advantages of computing biological data in research activities, need of speeding up research activities due to increasing prevalence of chronic diseases such as cancer and innovation of artificial intelligence are the major factors driving the computational biology market. The increasing demand of computational biology is due to the presence of opportunities for computational explorations for patterns and integration across rich available data sets. For example, in development of RNA sequencing, bioinformatics process is used in designing statistical framework for analyzing data and generating a gene expression matrix. The published single-cell RNA seq. papers in the literature have increased fivefold in past 5 years, with many of those papers have significant support from computational biologists which shows the effectiveness of computational biology in research activities which increases the demand of this market. Use of machine learning in computational biology is starting to become more and more important as it is being applied in genomics, proteomics and cancer detections for efficient result from research activities as well as for effective diagnosis. However, the main restraining factor for this market is the need for computational biologists to collaborate thoroughly with experimentalists and clinicians across the biomedical spectrum to conclude and finding results in any research activities. Growing funding initiatives from government bodies is expected to help in the computational biology market growth in forecast period.

Global Computational Biology Market Regional Analysis–

North America is currently dominating the computational biology market with highest market share due to government funding for genetic based studies, increase in public private partnerships and collaboration between pharmaceutical industries and academies. For example, US government has spent about USD 430 million on synthetic biology research, where Department of Energy (DOE) invested majority of this research since 2005. The field is still not explored that much as it is scattered among small groups, across both US and EU. The US is more developed region for synthetic and system biology in terms of activity and networking among scientific community. But, in case of Europe, they have spent approximately USD 160 million on synthetic biology research which is new sector of computational biology with slight decrease in funding shows the overall computational biology market being invested by both of these regions and is expected to have growing investment scenario due to emergence of disease such as novel corona virus. In case of Asia-Pacific region, it will have high growth rate due to population based studies, foreign investment and government initiatives. For example, the Synthetic and Systems Biology is at a nascent stage in India and The institutions involved in the research activity in this area comprises CSIR (Council of Scientific & Industrial Research) Laboratories, IISc (Indian Institute of Science), NCBS (National Centre for Biological Sciences), IIT-Kharagpur, Bose Institute, University of Kerala and a couple of companies with government of India support.

Report Analysis	Details
Historical data	2020-2025
Forecast Period	2026-2032
Market Size in 2026:	USD 16.44 billion
Base year considered	2025
Forecast Period CAGR %:	20.72 %
Market Size Expected in 2032:	USD 50.88 billion
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	Chemical Computing Group Inc,Compugen Ltd.,Leadscope Inc.,Genedata AG,Accelrys,Certara,Insilico Biotechnology AG,Rhenovia Pharma SAS,Simulation Plus Inc.,Entelos,Nimbus Discovery LLC,Dassault Systèmes,Others
Segments Covered	By Services, By Application, By End-Use
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Global Computational Biology Market Reports–

Global Computational Biology Market report covers in depth historical and forecast analysis.

Global Computational Biology Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Computational Biology Market report helps to identify opportunities in market place.

Global Computational Biology Market report covers extensive analysis of emerging trends and competitive landscape.

Global Computational Biology Market Segmentation –

By Applications

• Cellular & Biological Simulation
  • Computational Genomics
  • Computational Proteomics
  • Pharmacogenomics
  • Others
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trials
  • Phase I
  • Phase II
  • Phase III
• Human Body Simulation Software

By Services

• In-house
• Contract

By End-Use

• Academics
• Industry
• Commercial

Regional & Country Analysis

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA